cmAngio® vs SENSICARDIAC
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your clinical practice aims to enhance cardiovascular risk assessment for women by leveraging existing mammography data. This AI software is ideal for radiologists and cardiologists seeking to identify Breast Arterial Calcifications (BAC) on mammograms, providing valuable insights into a patient's cardiovascular health without requiring additional procedures or radiation. It's particularly useful for integrating cardiovascular screening into routine breast imaging workflows.
View cmAngio® →Choose SENSICARDIAC if…
Choose SENSICARDIAC if you require an AI-powered solution for real-time heart murmur detection and classification, especially in a telehealth or remote monitoring context. This tool is best suited for physicians, including pediatricians and internal medicine specialists, who need to quickly differentiate between pathological and physiological murmurs using electronic stethoscopes, thereby streamlining diagnosis and reducing unnecessary referrals. It's an excellent choice for enhancing initial cardiac screenings and remote patient evaluations.
View SENSICARDIAC →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | SENSICARDIAC |
|---|---|---|
| Pricing | Contact for details | Contact for pricing |
| Deployment | Cloud-based (inferred from similar CureMetrix products) | Cloud, Desktop (Windows) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngiou00ae (Tool A) emphasizes quick installation (less than an hour) and compatibility with any DICOM-compliant viewer, suggesting seamless integration into existing radiology workflows. While SENSICARDIAC (Tool B) offers a guided auscultation process and real-time analysis, its requirement for integration with specific electronic stethoscopes and a desktop application might introduce slightly more setup complexity compared to Tool A's purely software-based approach.
Clinical Value
TieBoth tools offer significant and distinct clinical value, are FDA-cleared, and address important health concerns. cmAngiou00ae (Tool A) leverages existing mammograms to provide early cardiovascular risk assessment without additional procedures, which is a valuable secondary use of routine imaging. SENSICARDIAC (Tool B) provides real-time, AI-powered classification of heart murmurs, directly aiding in diagnosis and potentially reducing unnecessary referrals.
Pricing & Value
cmAngio®Both tools lack transparent public pricing, requiring direct vendor contact. However, cmAngiou00ae (Tool A) explicitly mentions 'limited-time offers for no-cost implementation and service,' which could represent a substantial value proposition for potential adopters. SENSICARDIAC (Tool B) implies a subscription model and separate component purchases, which, while offering flexibility, doesn't suggest the same potential for initial cost savings.
Enterprise Readiness
SENSICARDIACBoth tools are FDA-cleared and HIPAA-compliant, indicating a foundational level of enterprise readiness. However, SENSICARDIAC (Tool B) explicitly states 'has_baa: yes' in its structured facts, providing clear transparency regarding Business Associate Agreement availability. cmAngiou00ae (Tool A) requires contacting the vendor for BAA details, which, while likely available, adds an extra step in the procurement process.
Innovation
SENSICARDIACWhile both utilize AI innovatively, SENSICARDIAC (Tool B) appears slightly more forward-looking in its application. It integrates AI-powered real-time heart murmur classification with electronic stethoscopes and offers 'LIVE diagnostic quality stethoscope streaming,' aligning strongly with advancements in telehealth and remote patient monitoring. cmAngiou00ae (Tool A) innovates by extracting new cardiovascular risk insights from existing mammography data, which is a clever repurposing, but Tool B's real-time, integrated diagnostic approach feels more cutting-edge in the context of advanced remote care.
Support & Docs
TieNeither the provided structured facts nor general web searches yielded specific details regarding the quality or availability of support and documentation for either cmAngiou00ae (Tool A) or SENSICARDIAC (Tool B). Both companies generally mention customer or technical support on their websites, but no comparative information is available to distinguish them.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | SENSICARDIAC |
|---|---|---|
| Primary AI Function | Detecting Breast Arterial Calcifications (BAC) | Heart murmur detection and classification (pathological or physiological) |
| Target Medical Condition | Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health | Heart murmurs |
| Input Data Type | Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200) |
| Output/Reporting | Visualization of BAC location on a scorecard, enables BAC identification and reporting | Detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators), classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological) |
| Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Internal Medicine, Pediatrics |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and SENSICARDIAC.